Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 7, 2025 -- For female patients with multiple sclerosis (MS), transcutaneous posterior tibial nerve stimulation (TPTNS) and repetitive transcranial magnetic stimulation (rTMS) are comparable for neurogenic overactive bladder symptoms, according to a study published online April 11 in Neurodegenerative Disease Management.
Pınar Atak Çakir, from Istanbul Medipol University, and colleagues randomly assigned 16 female patients with MS with neurogenic overactive bladder to receive TPTNS or rTMS for a pilot study. Treatments were applied for a total of 10 sessions over two consecutive weeks.
The researchers observed no significant change within and between the TPTNS and rTMS groups in urodynamic parameters. Significant improvement was seen in nocturia frequency in the TPTNS group compared with the rTMS group based on an analysis of parameters from a three-day voiding diary. There were no significant between-group changes seen in Overactive Bladder Questionnaire-V8, Incontinence Severity Index, or Incontinence Quality of Life Scale parameters.
"The TPTNS and rTMS methods we employed for the treatment of neurogenic overactive bladder are advantageous in that they have no side effects and are easy to apply, and they are suitable treatment options for female patients with MS," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Autoimmune Diseases Linked to Digestive System Cancers
FRIDAY, Aug. 15, 2025 -- Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of...
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 -- Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published...
Increase Seen in Physician Visits ~15 Years Before MS Onset
THURSDAY, Aug. 7, 2025 -- Health care use is increased years before onset of multiple sclerosis (MS), according to a study published online Aug. 1 in JAMA Network Open. Marta...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.